What does Amerisafe do and what are its main business segments?

What were the key takeaways from Amerisafe’s earnings call?

Did Amerisafe beat or miss consensus estimates last quarter?

What is the market's earnings forecast for Amerisafe next quarter?

What is Amerisafe's gross profit margin?

What guidance did Amerisafe's management provide for the next earnings period?

What factors drove the changes in Amerisafe's revenue and profit?

What were the key takeaways from Amerisafe's earnings call?

- **Strong Financials:** ROE of 18.5% and combined ratio of 91.3% reflect disciplined underwriting despite market challenges.
- **Topline Growth:** GPW up 11.7% Q4 and 6.7% annually, driven by voluntary premium and 93.7% policy retention.
- **Claims Pressure:** Loss ratio rose to 72% due to 25 claims over $1M, with medical inflation and wage growth contributing to severity.
- **Sustainable Growth:** 7 straight quarters of GPW growth, with agriculture and services segments leading expansion.
- **Investment Strength:** High-quality portfolio with 3.83% yield and $797M in liquid assets.

**【Management Opening Remarks】**
- CEO Janelle Frost highlighted a strong Q4 2025 with ROE of 18.5% and combined ratio of 91.3%, despite a prolonged soft market in workers' compensation.
- Emphasized disciplined underwriting, safety services, and claims management as key differentiators.

**【CEO & CFO Financial Commentary】**
- **Gross Premium Written (GPW):** Q4 2025 growth of 11.7% (vs. 3.9% in 2024), full-year growth of 6.7%, driven by voluntary premium (+10.2% annually).
- **Policy Retention:** 93.7% in Q4, with in-force policy count up 10.2% year-over-year.
- **Claims Performance:** Current accident year loss ratio rose to 72% (from 71% in 2024), driven by 25 claims over $1M (vs. 18 in 2024). Favorable prior-year development of $33.9M (12% of reserves).
- **Net Income:** $10.4M ($0.55/share) in Q4, down 15% year-over-year due to higher claims severity.
- **Investment Portfolio:** 3.83% book yield, high credit quality (AA-), and $797M in cash/assets.

**【Q&A Highlights】**
- **Claims Severity:** 25 large claims were spread across industries, with no single cause; medical inflation (e.g., home health, prosthetics) remains a pressure point.
- **Growth Sustainability:** 7 consecutive quarters of GPW growth driven by agent partnerships and renewal retention; agriculture and services segments showed strong growth.
- **Market Dynamics:** Rate declines expected to continue (~mid-single digits), but wage growth (+6.1% Q4) offsets some pressure.
- **Undocumented Workers:** No material impact on claims or premium collection observed.


AMERISAFE, Inc.(AMSF)-20260226-2025 Q4 Earnings call transcript

- **Topline Growth**: 7.2% increase in gross written premiums, fueled by 10.6% voluntary policy growth and 2.7% policy count expansion.
- **Profitability**: Operating net income of $10.6 million with a 31.1% expense ratio, reflecting strong cost control.
- **Capital Return**: $1.00 special dividend and $0.39 regular dividend, alongside $1.3 million in share buybacks.
- **Strategic Focus**: Emphasis on medical inflation mitigation, home health utilization, and maintaining competitive renewal rates.
- **Market Resilience**: Stable claims trends and disciplined underwriting in high-hazard industries drive consistent performance.

**【CEO Summary Section】**
- **Revenue Growth**: Gross written premiums increased 7.2% year-over-year, driven by 10.6% growth in voluntary policies and 2.7% policy count expansion. Renewal retention remained strong at 93.6%.
- **Strategic Focus**: Emphasis on disciplined underwriting, claims handling, and risk selection. Home health utilization and medical inflation are key areas of focus.
- **Capital Deployment**: Special dividend of $1.00 and regular dividend of $0.39 declared, alongside $1.3 million in share repurchases.
- **Market Position**: Competitive renewal rates and consistent underwriting approach differentiate AMERISAFE in high-hazard industries.

**【CFO Financial Commentary】**
- **Net Income**: $13.8 million for the quarter, with operating net income of $10.6 million.
- **Expense Management**: Expense ratio improved to 31.1%, reflecting operational efficiency.
- **Investment Portfolio**: $817 million in investments with a 3.9% tax-equivalent yield. Unrealized gains of $4.1 million in equity securities.
- **Capital Strength**: Book value per share increased 7.1% year-to-date, with statutory surplus of $259 million.

**【Q&A Highlights】**
- **Dividend Strategy**: Special dividend reflects confidence in growth sustainability, balancing capital return with reinvestment.
- **Medical Inflation**: Fee schedules mitigate cost pressures, though utilization trends remain under close watch.
- **Competitive Landscape**: Steady renewal rates and disciplined pricing maintain market share despite industry volatility.
- **Claims Handling**: Stable claim counts despite policy growth, driven by low frequency and effective claims management.
- **Expansion Strategy**: No immediate geographic expansion plans, focusing on market penetration and agent partnerships.

AMERISAFE, Inc. (AMSF) Q3 2025 Earnings Call Transcript

- **Topline Growth**: 12.8% voluntary premium growth and 3.4% policy count increase reflect strong new business and retention. 
- **Claims Efficiency**: 71% accident year loss ratio with $8.6M favorable development highlights claims expertise. 
- **Capital Allocation**: $25M share buyback program and $0.39 dividend demonstrate confidence in long-term value. 
- **Market Dynamics**: Industry softness persists (mid-single-digit loss cost declines), but medical severity up 6% in 2024 signals potential cycle shift. 
- **Financial Strength**: $807M investment portfolio with 3.85% yield and 4.5-year duration supports balance sheet resilience.

**【CEO Summary Section】**
- **Revenue Growth**: Voluntary premiums grew 12.8% YoY, driven by new business and 93.8% renewal retention. Policy count increased 3.4% QoQ and 5.8% YoY.
- **Market Position**: Workers' compensation remains profitable (industry combined ratio <100%), but NCCI reports 6% medical severity increase in 2024. AMERISAFE maintains focus on ES and G hazard classes (83-85% of policies).
- **Claims Performance**: Accident year loss ratio of 71% as of Q2, with $8.6M favorable claim development (2020+ accident years). 
- **Capital Management**: $25M share repurchase program reauthorized; Q2 repurchased 63,000 shares. Dividend of $0.39 per share declared.

**【CFO Financial Commentary】**
- **Net Income**: $14M ($0.73 EPS) vs. $11M ($0.57 EPS) YoY, driven by $4.9M equity gains. Operating net income: $10M ($0.53 EPS) vs. $11.1M ($0.58 EPS) YoY.
- **Top Line**: Gross written premiums $79.7M (+4.3% YoY), audit premiums declined $5.8M YoY. 
- **Expense Ratio**: 31.3% (vs. 29.8% YoY), driven by insurance assessments and audit premium mismatch. Full-year ratio expected to align with historical levels.
- **Investment Portfolio**: 3.85% tax-equivalent yield, 62% in municipal bonds. Book value per share $13.96 (+3.3% YTD).

**【Q&A Highlights】**
- **New Business Growth**: Agent count reduced 27% (2,200 → 1,600) but policy count increased, reflecting improved agent effectiveness. 
- **Policyholder Dividends**: Florida (largest state) policyholder dividends up due to competitive pricing and loss experience. 
- **Construction Trends**: Wage growth (+5%) offset by stable employee count; claims frequency risk from new hires vs. extended hours. 
- **Expense Ratio**: Historical range of ~30-31%, with Q2 at 31.3% and full-year expected to remain stable. 
- **Medical Inflation**: NCCI reports 6% severity increase, but AMERISAFE claims team maintains long-term reserving discipline.

AMERISAFE (AMSF)-25 Jul 25-2025 Q2 Earnings call transcript

- **Topline Growth**: 4.6% GWP expansion driven by new business (+7.1%) and strong retention (93.1%). 
- **Profitability Challenges**: 29.9% expense ratio up $1.9M due to timing delays in premium recognition. 
- **Investment Resilience**: 3.85% portfolio yield with high credit quality (AA-), despite $13.3M held-to-maturity unrealized loss. 
- **Key Risks**: Tariff exposure to 15% of med costs, moderating wage inflation (4%+), and physician fee increases (+4-5%).

**【CEO Summary Section】**
- **Gross Written Premiums (GWP) Growth**: 4.6% YoY to $83.8M, driven by new business gains (+7.1%) and 93.1% policy retention. Audit premium contributions declined to $5M (vs. $6.4M prior year). 
- **Competitive Environment**: Workers' comp rates declining 6-8% YoY, but niche industries (construction, trucking) show resilience. 
- **Claims Performance**: $8.7M favorable prior year case development, reflecting proactive claims handling. 
- **Economic Monitor**: Watching wage inflation (above 4% vs. national 4%), payroll trends, and project delays for premium impact. 

**【CFO Financial Commentary】**
- **Net Income**: $8.9M ($0.47 EPS) vs. $16.9M ($0.88 EPS) prior year, driven by $3.2M equity portfolio losses. 
- **Expense Ratio**: 29.9% (vs. 27.3%), up $1.9M due to business investments timing lag. 
- **Investment Portfolio**: 3.85% tax-equivalent yield, 62% in municipal bonds, 54% held-to-maturity with $13.3M unrealized loss. 
- **Capital Strength**: $826M in investments/cash, 17.1% operating ROE, $243.6M statutory surplus. 

**【Q&A Key Takeaways】**
1. **Audit Premium Trends**: Q2'24: $7.3M, Q3'24: $4M, Q4'24: $2.5M, reflecting moderating wage inflation. 
2. **Tariff Impact**: 15% of med costs exposed to tariffs (pharmacy/durable equipment), potential 0.5-1% cost increase. 
3. **Medical Inflation**: Physician fee increases (+4-5%), offset by fee schedule repricing. 
4. **Large Losses**: 2 incidents below trend, supporting 71% accident year loss ratio. 
5. **State Rate Actions**: 2 rate increases vs. 14% declines, industry redundancy expected to decline.

AMERISAFE (AMSF)-30 Apr 25-2025 Q1 Earnings call transcript

- **Topline Growth**: 3.9% Q4 and 3.1% full year gross premium growth, 9.6% policy count expansion.
- **Profitability**: 88.7% combined ratio, 20.2% ROE, stable 71% loss ratio.
- **Capital Strength**: $830M investment portfolio, 5.4% dividend increase.
- **2025 Focus**: Maintain 71% loss ratio, moderate audit premium growth, competitive high-hazard strategy.
- **Claims Efficiency**: 99% pre-2019 claims closed, 18 large claims (> $1M) in 2024.

**【CEO Summary Section】**
- **Revenue Growth**: Gross premiums written increased 3.9% Q4 and 3.1% full year 2024, driven by 8.5% voluntary premium growth and 9.6% policy count growth.
- **Profitability Metrics**: Combined ratio of 88.7%, ROE of 20.2%, and stable accident year loss ratio at 71%.
- **Leverage Opportunities**: 2024 favorable prior year development of $34.9M ($9.7M Q4), offsetting industry headwinds like rate reductions.
- **Capital Management**: 5.4% dividend increase to $0.39/share.

**【CFO Financial Commentary】**
- **Net Income**: $13.2M ($0.69 EPS) Q4 vs. $19.2M ($1.00 EPS) prior year, driven by lower unrealized gains.
- **Premium Growth**: Net premiums earned up 1.2% Q4 and 1.3% full year, supported by strong retention (94.1% policy, 88% premium).
- **Expense Control**: Expense ratio 29.7% Q4 (vs. 28.9% prior year), reflecting higher operating expenses relative to premium growth.
- **Investment Portfolio**: 3.8% tax-equivalent yield, $830M in investments, 56% held-to-maturity bonds with 4.4-year duration.
- **Book Value**: $13.51/share after special dividend, operating ROE 17.5% Q4 and 17.1% full year.

**【Q&A Highlights】**
- **Policy Growth Drivers**: 2.6% Q4 policy count growth vs. 9.6% full year, 4% Q4 payroll growth vs. 7% prior quarters.
- **Average Policy Size**: Slightly lower 2024 vs. 2023, but higher than national wage growth trends.
- **Claims Performance**: 99% pre-2019 claims closed, 18 claims >$1M in 2024 (vs. 9 in 2023), consistent with book of business.
- **2025 Outlook**: Maintain 71% loss ratio, moderate audit premium growth, competitive focus on high-hazard risks.
- **Medical Inflation**: Mid-single-digit loss cost decreases, home health costs remain key focus area.

Actual											0.88	1	1.16	1.22	0.76	1.04	1.02	-0.0028	0.82	0.68	0.73	0.84	0.83	0.73	0.61	0.74	0.69	0.58	0.58	0.67	0.6	0.53	0.55	0.51
Forecast											0.791	0.6903	0.7245	0.9535	0.7317	0.7338	0.7726	0.9247	0.6605	0.6692	0.7475	0.7744	0.7148	0.7223	0.6887	0.7078	0.7021	0.6256	0.5849	0.6246	0.6101	0.5404	0.5582	0.603
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+11.25%	+44.86%	+60.11%	+27.95%	+3.87%	+41.73%	+32.02%	-100.30%	+24.15%	+1.61%	-2.34%	+8.47%	+16.12%	+1.07%	-11.43%	+4.55%	-1.72%	-7.29%	-0.84%	+7.27%	-1.66%	-1.92%	-1.47%	-15.42%

AMSF

AMSF fundamentals

AMSF Q4 2025 Earnings

Earnings Call

You can ask Aime

AMSF

AMSF fundamentals

AMSF Q4 2025 Earnings

Earnings Call

AMSF Earnings Call Summary for Q4/202510:30 AM on Feb 26, 2026

AMSF Earnings Call Summary for Q3/202510:30 AM on Oct 30, 2025

AMSF Earnings Call Summary for Q2/202510:30 AM on Jul 25, 2025

AMSF Earnings Call Summary for Q1/202510:30 AM on Apr 30, 2025

AMSF Earnings Call Summary for Q4/202410:30 AM on Feb 27, 2025

You can ask Aime